Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announcement on Progress of Guarantees Provided by the Company for Subsidiaries within the Consolidated Financial Statements Scope
The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and do not contain any false representations, misleading statements, or material omissions.
I. Overview of Guarantee Situation
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held its Eighth Board of Directors' 20th Meeting on April 24, 2025, and its 2024 Annual General Meeting on May 19, 2025. The proposal "Proposal on the Limit of Guarantees Provided by the Company for Subsidiaries within the Consolidated Financial Statements Scope" was deliberated and approved. To coordinate the production and operation activities of subsidiaries (hereinafter referred to as "subsidiaries within the Company's consolidated financial statements scope," and the same below), ensure their sustained development, and improve the efficiency of capital utilization, the Company will continue to provide joint liability guarantees for bank credit business for its subsidiaries, with a total limit not exceeding RMB 2 billion. The Chairman is authorized to implement relevant matters and sign relevant documents within the aforementioned limit based on specific circumstances.
For detailed information, please refer to the relevant announcements published by the Company on April 26, 2025, and May 20, 2025, in the "Securities Times" and on the Juchao Information Network (www.cninfo.com.cn).